Miraculins Inc.
TSX VENTURE : MOM

Miraculins Inc.

May 25, 2006 18:17 ET

Miraculins Announces Board of Directors

WINNIPEG, MANITOBA--(CCNMatthews - May 25, 2006) - Miraculins Inc. (TSX VENTURE:MOM), a biotechnology company engaged in the discovery and development of products for select cancers, is pleased to announce the re-election of Dr. Albert Friesen, Dr. Phiet Bui, Mr. David Filmon, Mr. Peter de Visser and Mr. Ted Paetkau to the Company's Board of Directors at today's Annual General and Special Meeting of Shareholders. As his current employment precludes his participation as a Director with other firms, Dr. Vincent Lenaerts did not stand for re-election to the Miraculins Board. Miraculins wishes to express its appreciation to Dr. Lenaerts for his contributions made during his tenure.

About Miraculins Inc.

Miraculins is a biotechnology company focused on commercializing products for the diagnosis and treatment of select cancers. The Company's lead product focuses on improving the diagnosis of prostate cancer.

Certain information contained in this press release may be forward-looking and is subject to risks and uncertainties. Although the Company believes that the expectations contained herein are reasonable, it can give no assurances such forward-looking statements will prove correct. Information is provided from sources deemed to be reliable.

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release.

Contact Information